A
Antag Therapeutics
Biotech & Life Sciences · Copenhagen, Denmark · Founded 2017
Antag Therapeutics – Therapeutic peptides for the treatment of obesity MoreLess
Antag Therapeutics is a pioneering biotech company focused on developing innovative therapies for metabolic diseases, particularly obesity and type 2 diabetes. Operating in the global healthcare market, Antag Therapeutics serves patients suffering from these conditions, which are often exacerbated by excessive caloric intake and inactive lifestyles. The company employs a business model centered on the research, development, and commercialization of novel treatment approaches that address the shortcomings of current pharmacological interventions, such as tolerability issues, weight gain, and loss of efficacy over time. Antag Therapeutics generates revenue through the development and licensing of its proprietary compounds, as well as potential partnerships with larger pharmaceutical companies. The company's leadership team boasts extensive experience in biotech, venture capital investment, and the commercialization of innovative medical solutions.
Keywords: metabolic diseases, obesity, type 2 diabetes, biotech, innovative therapies, pharmacological interventions, healthcare market, proprietary compounds, commercialization, venture capital.
Company overview
Antag Therapeutics company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2017
- Headquarters
- Copenhagen, Denmark
- Employees
- 22
- Open positions
- None listed
- Dealroom signal
- 78.9
Valuation & funding
Antag Therapeutics funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Dec 2024 | $88M | $352M | Pictet · Longview Ventures · Export and Investment Fund of Denmark · SR One | ↗ |
| LATE VCOther financing | Jun 2020 | $3.5M | $14M | Broadview Ventures | — |
| SPINOUTOther financing | Dec 2017 | $0 | — | Technical University of Denmark | — |
| SERIES AOther financing | Jul 2017 | $2.9M | $12M | Novo Ventures · Novo Seeds | — |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
| Year | Revenue | Growth | EBITDA | Margin |
|---|---|---|---|---|
| 2026 | $34K | 0% | −$1.7M | -5001.2% |
| 2025 | $34K | 0% | −$1.7M | -5001.2% |
| 2024 | $34K | 0% | −$1.7M | -5001.2% |
| 2023 | $34K | 0% | −$1.7M | -5001.2% |
| 2022 | $34K | 0% | −$1.7M | -5001.2% |
| 2021 | $34K | 0% | −$2.3M | -6905.6% |
| 2020 | $34K | — | −$2.2M | -6412.4% |
Growth signals
Antag Therapeutics website traffic
Latest recorded traffic for Antag Therapeutics is 3.8K monthly website visits, up 192.3% over the last three months. Antag Therapeutics's team grew 0% over the past year.
Comparisons
Antag Therapeutics compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Antag Therapeutics's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Antag Therapeutics has talent and traffic
team presence
In the news
Latest news about Antag Therapeutics
Recent press, funding announcements, and product moves mentioning Antag Therapeutics — open to read from the original sources.
Market sentiment
What the market is saying about Antag Therapeutics
An AI-synthesized read of the highest-engagement posts about Antag Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Antag Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.